Evista (chemical name: raloxifene) is a selective estrogen receptor modulator (SERM) approved by the FDA to treat and prevent osteoporosis in postmenopausal women.
Evista also is approved to reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women diagnosed with osteoporosis, as well as postmenopausal women who don’t have osteoporosis but who are at higher-than-average risk for breast cancer.
Evista is a pill taken by mouth once a day.
Learn more about Evista.
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...